These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34766126)

  • 1. Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.
    Guo C; Dong E; Lai Q; Zhou S; Zhang G; Wu M; Yue X; Tao Y; Peng Y; Ali J; Lu Y; Fu Y; Lai W; Zhang Z; Ma F; Yao Y; Gou L; Yang H; Yang J
    MedComm (2020); 2020 Dec; 1(3):338-350. PubMed ID: 34766126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer.
    Owens GL; Sheard VE; Kalaitsidou M; Blount D; Lad Y; Cheadle EJ; Edmondson RJ; Kooner G; Gilham DE; Harrop R
    J Immunother; 2018 Apr; 41(3):130-140. PubMed ID: 29239915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
    Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
    Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.
    Guo X; Zheng H; Luo W; Zhang Q; Liu J; Yao K
    Sci Rep; 2017 Jul; 7(1):4859. PubMed ID: 28687750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
    Harrop R; O'Neill E; Stern PL
    Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.
    Tykodi SS; Satoh S; Deming JD; Chou J; Harrop R; Warren EH
    J Immunother; 2012 Sep; 35(7):523-33. PubMed ID: 22892449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
    Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
    Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer.
    Zhang BL; Li D; Gong YL; Huang Y; Qin DY; Jiang L; Liang X; Yang X; Gou HF; Wang YS; Wei YQ; Wang W
    Hum Gene Ther; 2019 Apr; 30(4):402-412. PubMed ID: 30693795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective Targeting of TAG72
    Murad JP; Kozlowska AK; Lee HJ; Ramamurthy M; Chang WC; Yazaki P; Colcher D; Shively J; Cristea M; Forman SJ; Priceman SJ
    Front Immunol; 2018; 9():2268. PubMed ID: 30510550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors
    Koneru M; Purdon TJ; Spriggs D; Koneru S; Brentjens RJ
    Oncoimmunology; 2015 Mar; 4(3):e994446. PubMed ID: 25949921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice.
    Li T; Wang J
    BMC Cancer; 2020 Jul; 20(1):678. PubMed ID: 32689954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
    Stern PL; Harrop R
    Cancer Immunol Immunother; 2017 Apr; 66(4):415-426. PubMed ID: 27757559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
    Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice.
    Hong H; Brown CE; Ostberg JR; Priceman SJ; Chang WC; Weng L; Lin P; Wakabayashi MT; Jensen MC; Forman SJ
    PLoS One; 2016; 11(1):e0146885. PubMed ID: 26761817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin.
    Zhang Z; Liu C; Wang M; Sun R; Yang Z; Hua Z; Wu Y; Wu M; Wang H; Qiu W; Yin H; Yang M
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T-cell recognition of human 5T4 oncofetal antigen.
    Smyth LJ; Elkord E; Taher TE; Jiang HR; Burt DJ; Clayton A; van Veelen PA; de Ru A; Ossendorp F; Melief CJ; Drijfhout JW; Dermime S; Hawkins RE; Stern PL
    Int J Cancer; 2006 Oct; 119(7):1638-47. PubMed ID: 16646078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based adoptive T cell targeting CA125 in ovarian cancer.
    Zhao H; Wu L; Dai J; Sun K; Zi Z; Guan J; Zhang L
    J Transl Med; 2023 Sep; 21(1):596. PubMed ID: 37670338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
    Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
    Front Immunol; 2021; 12():665970. PubMed ID: 34475869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.
    Chekmasova AA; Rao TD; Nikhamin Y; Park KJ; Levine DA; Spriggs DR; Brentjens RJ
    Clin Cancer Res; 2010 Jul; 16(14):3594-606. PubMed ID: 20628030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.
    Rodriguez-Garcia A; Sharma P; Poussin M; Boesteanu AC; Minutolo NG; Gitto SB; Omran DK; Robinson MK; Adams GP; Simpkins F; Powell DJ
    Mol Ther; 2020 Feb; 28(2):548-560. PubMed ID: 31870622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.